Infectious Disease
Appendicitis
48
Pipeline Programs↗
10
Active Trials↗
13
Companies Involved↗
Appendicitis is a moderately active landscape with 48 programs across 13 companies. The most active players are Melinta Therapeutics, Inc., Eyegate Pharmaceuticals, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd.. 16 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical23
Phase 27
Analysis
Trial Status
59
clinical trials
Completed35 · 59%
Unknown status8 · 14%
Active, not recruiting4 · 7%
Recruiting4 · 7%
Withdrawn3 · 5%
Terminated3 · 5%
Other2 · 3%
Clinical Trials
Trial Activity
59 trials
The Value of Post-operative Antibiotic Therapy After Laparoscopic Appendectomy for Complicated Acute Appendicitis (Other Than for Generalized Peritonitis)
Recruiting·—·Phase 3·NCT03688295·1,476 enrolled
Antibiotics vs Surgery in Acute Appendicitis
Active, not recruiting·—·N/A·NCT07492329·400 enrolled
Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis
Active, not recruiting·RResearch Institute for Physical Chemical Problems of the Belarusian State University·Phase 2·NCT06365632·100 enrolled
The Role of Contrast Enhanced Ultrasound in Appendicitis
Completed·—·Phase 2·NCT03687502·37 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)